$624 Million is the total value of SECTOR GAMMA AS's 37 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 20.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $61,971,000 | -11.9% | 965,433 | -30.4% | 9.92% | -16.5% |
| ABT | Buy | ABBOTT LABS | $49,162,000 | +9.4% | 565,997 | +5.3% | 7.87% | +3.7% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $46,894,000 | +4.0% | 1,037,023 | -6.4% | 7.51% | -1.4% |
| MRK | New | MERCK & CO INC | $32,269,000 | – | 354,795 | +100.0% | 5.17% | – |
| BIIB | Buy | BIOGEN INC | $30,331,000 | +148.5% | 102,219 | +95.0% | 4.86% | +135.6% |
| NUVA | Sell | NUVASIVE INC | $29,975,000 | +1.0% | 387,580 | -17.2% | 4.80% | -4.2% |
| PKI | Buy | PERKINELMER INC | $29,916,000 | +17.0% | 308,099 | +2.6% | 4.79% | +10.9% |
| GILD | Sell | GILEAD SCIENCES INC | $27,006,000 | -10.3% | 415,605 | -12.5% | 4.32% | -15.0% |
| INCY | Sell | INCYTE CORP | $24,672,000 | -3.9% | 282,542 | -18.3% | 3.95% | -8.9% |
| A | Buy | AGILENT TECHNOLOGIES INC | $23,753,000 | +19.1% | 278,427 | +7.0% | 3.80% | +12.9% |
| ANTM | Buy | ANTHEM INC | $23,108,000 | +29.0% | 76,508 | +2.5% | 3.70% | +22.3% |
| BRKR | Buy | BRUKER CORP | $17,419,000 | +28.7% | 341,750 | +11.0% | 2.79% | +22.0% |
| JNJ | New | JOHNSON & JOHNSON | $17,100,000 | – | 117,229 | +100.0% | 2.74% | – |
| BIO | Sell | BIO RAD LABS INCcl a | $16,603,000 | +7.6% | 44,870 | -3.2% | 2.66% | +2.0% |
| HUM | Buy | HUMANA INC | $16,589,000 | +47.5% | 45,261 | +2.9% | 2.66% | +39.8% |
| QGEN | Sell | QIAGEN NV | $14,673,000 | -8.2% | 434,111 | -10.4% | 2.35% | -13.0% |
| PRGO | Buy | PERRIGO CO PLC | $14,085,000 | -2.3% | 272,644 | +5.7% | 2.26% | -7.4% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $13,645,000 | +54.9% | 126,164 | +40.2% | 2.18% | +46.7% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $13,266,000 | +12.3% | 150,615 | +1.7% | 2.12% | +6.5% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $13,147,000 | +66.9% | 217,635 | +65.5% | 2.11% | +58.2% |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $12,766,000 | +15.1% | 433,477 | +3.9% | 2.04% | +9.1% |
| CAH | Buy | CARDINAL HEALTH INC | $10,751,000 | +15.5% | 212,563 | +7.7% | 1.72% | +9.5% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $10,685,000 | -49.2% | 28,458 | -62.5% | 1.71% | -51.9% |
| PDCO | Buy | PATTERSON COMPANIES INC | $9,776,000 | +16.9% | 477,355 | +1.7% | 1.57% | +10.8% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $9,449,000 | -1.9% | 65,864 | +1.7% | 1.51% | -7.0% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $9,191,000 | +24.2% | 215,196 | +24.4% | 1.47% | +17.8% |
| DGX | New | QUEST DIAGNOSTICS INC | $8,220,000 | – | 76,976 | +100.0% | 1.32% | – |
| THC | Sell | TENET HEALTHCARE CORP | $6,499,000 | -31.6% | 170,896 | -60.2% | 1.04% | -35.2% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $6,333,000 | – | 74,903 | +100.0% | 1.01% | – |
| BLUE | New | BLUEBIRD BIO INC | $5,476,000 | – | 62,400 | +100.0% | 0.88% | – |
| PTCT | Sell | PTC THERAPEUTICS INC | $4,813,000 | +17.2% | 100,202 | -17.5% | 0.77% | +11.1% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $4,260,000 | +151.2% | 408,625 | -5.3% | 0.68% | +137.6% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $3,119,000 | -7.6% | 130,625 | +3.7% | 0.50% | -12.4% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $3,052,000 | -8.5% | 63,913 | -37.9% | 0.49% | -13.1% |
| LLY | Sell | LILLY ELI & CO | $2,040,000 | -88.0% | 15,524 | -89.8% | 0.33% | -88.6% |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $1,772,000 | -22.2% | 211,698 | -15.9% | 0.28% | -26.2% |
| TAK | Sell | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $609,000 | -95.7% | 30,873 | -96.2% | 0.10% | -95.9% |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -96,900 | -100.0% | -1.32% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -472,305 | -100.0% | -6.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.